For the year ending 2025-12-31, PGEN made $9,684K in revenue. -$429,642K in net income. Net profit margin of -4436.62%.
| Income Statement | 2025-12-31 | |||
|---|---|---|---|---|
| Total revenues | 9,684 | |||
| Cost of products and services | 4,823 | |||
| Research and development | 41,333 | |||
| Selling, general and administrative | 70,128 | |||
| Impairment of goodwill | 3,907 | |||
| Impairment of other noncurrent assets | 0 | |||
| Total operating expenses | 120,191 | |||
| Operating loss | -110,507 | |||
| Change in fair value of warrant liabilities | -139,523 | |||
| Interest expense | 3,867 | |||
| Interest income | 3,215 | |||
| Other income, net | 43 | |||
| Total other (expense) income, net | -140,132 | |||
| Loss before income taxes | -250,639 | |||
| Income tax (expense) benefit | 3 | |||
| Net loss | -250,642 | |||
| Deemed dividend on preferred stock | 179,000 | |||
| Net loss attributable to common shareholders | -429,642 | |||
| Basic EPS | -1.37 | |||
| Diluted EPS | -1.37 | |||
| Basic Average Shares | 312,980,562 | |||
| Diluted Average Shares | 312,980,562 | |||
PRECIGEN, INC. (PGEN)
PRECIGEN, INC. (PGEN)